MAPK14 and infection: The authors investigated others pharmacological inhibitors of MAPK that were upregulated during infection (Table 2) and significant antiviral activity was observed for gilteritinib (AXL kinase inhibitor), ralimetinib (MAPK11 and MAPK14 inhibitor), MAPK13-IN-1 (MAPK13 inhibitor) and ARRY-797 (MAPK14 inhibitor).